These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1138 related articles for article (PubMed ID: 26453594)

  • 1. Current management of diabetes mellitus and future directions in care.
    Chatterjee S; Davies MJ
    Postgrad Med J; 2015 Nov; 91(1081):612-21. PubMed ID: 26453594
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 4. How technology has changed diabetes management and what it has failed to achieve.
    Ratheau L; Jeandidier N; Moreau F; Sigrist S; Pinget M
    Diabetes Metab; 2011 Dec; 37 Suppl 4():S57-64. PubMed ID: 22208712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Impact of Technology on Current Diabetes Management.
    Garvey K; Wolfsdorf JI
    Pediatr Clin North Am; 2015 Aug; 62(4):873-88. PubMed ID: 26210622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Closing the Loop.
    Nimri R; Yakoob H; Schoenberg B; Dassau E
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 1():S29-42. PubMed ID: 26836427
    [No Abstract]   [Full Text] [Related]  

  • 7. Emerging diabetes therapies and technologies.
    Moser EG; Morris AA; Garg SK
    Diabetes Res Clin Pract; 2012 Jul; 97(1):16-26. PubMed ID: 22381908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An artificial pancreas for automated blood glucose control in patients with Type 1 diabetes.
    Schmidt S; Boiroux D; Ranjan A; Jørgensen JB; Madsen H; Nørgaard K
    Ther Deliv; 2015; 6(5):609-19. PubMed ID: 26001176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Automated insulin pump suspension for hypoglycaemia mitigation: development, implementation and implications.
    Davis T; Salahi A; Welsh JB; Bailey TS
    Diabetes Obes Metab; 2015 Dec; 17(12):1126-32. PubMed ID: 26179879
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Closed loop insulin delivery in diabetes.
    Battelino T; Omladič JŠ; Phillip M
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):315-25. PubMed ID: 26051293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress of artificial pancreas devices towards clinical use: the first outpatient studies.
    Russell SJ
    Curr Opin Endocrinol Diabetes Obes; 2015 Apr; 22(2):106-11. PubMed ID: 25692927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New technology and diabetes management.
    Kowalski A
    Am J Nurs; 2007 Jun; 107(6 Suppl):16-7. PubMed ID: 17563427
    [No Abstract]   [Full Text] [Related]  

  • 13. New and Emerging Technologies in Type 1 Diabetes.
    Sherwood JS; Russell SJ; Putman MS
    Endocrinol Metab Clin North Am; 2020 Dec; 49(4):667-678. PubMed ID: 33153673
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New frontiers in the management of type 2 diabetes.
    Mudaliar S
    Indian J Med Res; 2007 Mar; 125(3):275-96. PubMed ID: 17496356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Type 1 diabetes technology: advances and challenges.
    The Lancet Diabetes Endocrinology
    Lancet Diabetes Endocrinol; 2019 Sep; 7(9):657. PubMed ID: 31439271
    [No Abstract]   [Full Text] [Related]  

  • 16. Transforming type 1 diabetes: the next wave of innovation.
    Drucker DJ
    Diabetologia; 2021 May; 64(5):1059-1065. PubMed ID: 33550440
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multicenter outpatient dinner/overnight reduction of hypoglycemia and increased time of glucose in target with a wearable artificial pancreas using modular model predictive control in adults with type 1 diabetes.
    Del Favero S; Place J; Kropff J; Messori M; Keith-Hynes P; Visentin R; Monaro M; Galasso S; Boscari F; Toffanin C; Di Palma F; Lanzola G; Scarpellini S; Farret A; Kovatchev B; Avogaro A; Bruttomesso D; Magni L; DeVries JH; Cobelli C; Renard E;
    Diabetes Obes Metab; 2015 May; 17(5):468-76. PubMed ID: 25600304
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Continuous Glucose Monitoring, Future Products, and Update on Worldwide Artificial Pancreas Projects.
    Kropff J; DeVries JH
    Diabetes Technol Ther; 2016 Feb; 18 Suppl 2(Suppl 2):S253-63. PubMed ID: 26784131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin therapy in type 2 diabetes.
    Mudaliar S; Edelman SV
    Endocrinol Metab Clin North Am; 2001 Dec; 30(4):935-82. PubMed ID: 11727406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review of a commercially available hybrid closed-loop insulin-delivery system in the treatment of Type 1 diabetes.
    Stone JY; Haviland N; Bailey TS
    Ther Deliv; 2018 Feb; 9(2):77-87. PubMed ID: 29235423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.